HIGH-DOSE INTRAVENOUS ESTROGEN THERAPY IN ADVANCED PROSTATIC-CARCINOMA - USE OF SERUM PROSTATE-SPECIFIC ANTIGEN TO MONITOR RESPONSE

被引:46
作者
FERRO, MA
GILLATT, D
SYMES, MO
SMITH, PJB
机构
[1] BRISTOL ROYAL INFIRM & GEN HOSP,DEPT UROL,BRISTOL BS2 8HW,AVON,ENGLAND
[2] BRISTOL ROYAL INFIRM & GEN HOSP,UNIV DEPT SURG,BRISTOL BS2 8HW,AVON,ENGLAND
关键词
D O I
10.1016/0090-4295(89)90248-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:134 / 138
页数:5
相关论文
共 15 条
[1]   BIOAVAILABILITY, DISTRIBUTION AND PHARMACOKINETICS OF DIETHYLSTILBESTROL PRODUCED FROM STILPHOSTROL [J].
ABRAMSON, FP ;
MILLER, HC .
JOURNAL OF UROLOGY, 1982, 128 (06) :1336-1339
[2]  
BAND PR, 1973, CAN MED ASSOC J, V109, P697
[3]  
COLAPINTO V, 1961, Br J Urol, V33, P171
[4]   EFFECT OF STILBESTROL AND TESTOSTERONE ON THE INCORPORATION OF 75-SELENOMETHIONINE BY PROSTATIC-CARCINOMA CELLS [J].
FERRO, MA ;
HEINEMANN, D ;
SMITH, PJB ;
SYMES, MO .
BRITISH JOURNAL OF UROLOGY, 1988, 62 (02) :166-172
[5]   TUMOR-MARKERS IN PROSTATIC-CARCINOMA - A COMPARISON OF PROSTATE-SPECIFIC ANTIGEN WITH ACID-PHOSPHATASE [J].
FERRO, MA ;
BARNES, I ;
ROBERTS, JBM ;
SMITH, PJB .
BRITISH JOURNAL OF UROLOGY, 1987, 60 (01) :69-73
[6]  
FLOCKS R H, 1955, J Urol, V74, P549
[7]  
Hawtrey C E, 1974, Urology, V4, P431, DOI 10.1016/0090-4295(74)90013-2
[8]  
HEAP G, 1976, BRIT J UROL, V48, P152
[9]  
KILLIAN CS, 1985, CANCER RES, V45, P886
[10]  
PARTON I, 1965, Br J Urol, V37, P314, DOI 10.1111/j.1464-410X.1965.tb09605.x